ACTIVAERO ERNENNT DR. ULRICH DAUER ZUM CHIEF STRATEGY OFFICER
(Thomson Reuters ONE) -
Activaero GmbH /
ACTIVAERO ERNENNT DR. ULRICH DAUER ZUM CHIEF STRATEGY OFFICER
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Gemuenden/Wohra, Germany, November 08, 2013 - Activaero GmbH, the therapeutic
area specialist for respiratory diseases focusing on novel, pharmacoeconomically
meaningful treatment solutions for severe lung diseases, today announced the
appointment of Dr. Ulrich Dauer as Chief Strategy Officer. He joins at a time
when the Company is progressing fastly towards the filing for approval of its
lead product for the treatment of severe asthma, FAVOLIR®, in Europe. He will be
responsible for the Company's corporate development strategy and the
implementation of the respective financing needed.
Through his previous position as founding member and CEO of the discovery and
development company 4SC AG since 2000, Dr Dauer is a well-known executive in the
healthcare industry as well as in the financial community. Following the listing
of 4SC in the Prime Standard of the Frankfurt Stock Exchange in 2005, he has
designed and established the Company's growth strategy based on collaboration
and licensing partnerships with international pharmaceutical and biotech
companies and fund raisings via capital markets with a combined volume of EUR
150 million. Dr. Dauer received his PhD from the Institute of Organic Chemistry
at the University of Wuerzburg.
"As Activaero is facing a variety of strategic options with the fast progress we
are making in our programs, we are warmly welcoming Ulrich with his experienced
leadership personality", commented Dr. Gerhard Scheuch, Founder and Chief
Executive Officer of Activaero GmbH. "In his previous position, he successfully
demonstrated that he can lead a company through a period of accelerated growth,
providing access to capital markets and always focusing on a well-balanced risk-
reward ratio. Furthermore, his international network in industry and finance is
of great value to us."
"Activaero is currently one of the most exciting life sciences companies", said
Dr. Ulrich Dauer, Chief Strategy Officer of Activaero GmbH. "The Company's
proprietary inhalation approach addresses a high medical need in the growing
market of respiratory diseases. Since the Company's innovative therapies are
based on highly efficacious but therapeutically not fully exploited drugs
without the digital risk of novel drug development, the equity story is highly
attractive for today's investors. I am excited to become part of the team at a
pivotal phase of the company's development and make my contribution to
Activaero's further progress."
About Activaero
Activaero is a therapeutic area specialist developing new, pharmacoeconomically
meaningful treatment solutions for patients suffering from severe respiratory
diseases, including Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic
Fibrosis (CF), Idiopathic Pulmonary Fibrosis (IPF) and Pulmonary Hypertension.
Activaero was founded in 1998 in Germany and is a privately held company with
offices in Germany near Frankfurt and Munich as well as in Dublin, Ohio (USA).
www.activaero.de
Contact us:
Activaero GmbH Media Contact
Dr. Gerhard Scheuch Anne Hennecke
Chief Executive Officer MC Services AG
t: +49-6453-64818-16 t: +49-211-529252-22
e: info(at)activaero.de e: anne.hennecke(at)mc-services.eu
www.activaero.de
Press release (PDF):
http://hugin.info/156033/R/1741779/585330.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Activaero GmbH via Thomson Reuters ONE
[HUG#1741779]
Unternehmensinformation / Kurzprofil:
Datum: 08.11.2013 - 10:06 Uhr
Sprache: Deutsch
News-ID 314355
Anzahl Zeichen: 4533
contact information:
Town:
Gemuenden/Wohra
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ACTIVAERO ERNENNT DR. ULRICH DAUER ZUM CHIEF STRATEGY OFFICER"
steht unter der journalistisch-redaktionellen Verantwortung von
Activaero GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
